New 'Sandwich' treatment aims to shrink tumors faster, protect lungs
NCT ID NCT07418866
Summary
This study is testing a new combination of radiation and drug therapy for people with advanced non-small cell lung cancer (NSCLC). Researchers want to see if a new 'high-low' radiation dose strategy, given after two cycles of chemotherapy and immunotherapy drugs, can shrink tumors more effectively while reducing the risk of lung damage. The goal is to better control the disease in 70 participants who have not had prior chest radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.